keyboard_arrow_up

Pharmaceutical Companies ICT landscape is set to change in 2014

ICT investment trends in pharmaceuticals - Enterprise ICT spending patterns through to the end of 2015 is a new market research publication announced by Reportstack. This report presents the findings from a survey of 113 pharmaceutical companies regarding their Information & Communications Technology (ICT) investment trends. The survey investigates how pharmaceutical companies currently allocate their ICT budgets across the core areas of enterprise ICT expenditure: hardware, software, IT services, communications, and consulting.

Key Findings
• The survey of 113 pharmaceutical companies highlights that X% of respondents anticipate an increase in their ICT budgets in 2014, which is an increase of X% compared to 2013.
• According to survey, pharmaceutical companies are planning to invest X% of their external ICT budgets in hardware, software, and IT services in 2014, which is more than the combined allocation in 2013 (X%).
• Pharmaceutical companies are allocating the highest proportion of their software budgets to application lifecycle management (X%) followed by enterprise applications (X%) and information management (X%) in 2013.

Synopsis
This report presents the findings from a survey of 113 pharmaceutical companies regarding their Information & Communications Technology (ICT) investment trends. The survey investigates how pharmaceutical companies currently allocate their ICT budgets across the core areas of enterprise ICT expenditure: hardware, software, IT services, communications, and consulting.

The report illustrates the core technologies enterprises are investing in, including business intelligence, content management, and cloud computing. The survey also highlights the approach adopted by the pharmaceutical companies to purchase technology. Through survey, the report aims to provide better insight to ICT vendors and services providers when pitching their solutions to pharmaceutical companies.

In particular, it provides an in-depth analysis of the following:
• Understand how ICT budgets are set to change in 2014 in terms of their overall size.
• Appreciate how IT budgets are allocated across the core elements of IT spend, including hardware, software, services, communications, and consulting.
• Learn how IT money is being spent in areas such as the data centre, applications, IT management and the network.
• Gain an understanding regarding which ICT functions pharmaceutical companies are interested in outsourcing.
• Identify pharmaceutical companies’ investment priorities based on their budget allocations across core technology categories such as business intelligence, content management and cloud computing. 
• Learn about the drivers that are influencing pharmaceutical companies’ investments in each technology category.
• Establish how pharmaceutical companies IT budgets are currently allocated across various segments within a technology category.
• Gain insight into how pharmaceutical companies plan to change their ICT budget allocations across various segments within a technology category.
• Understand the vendor mindshare for various core and advanced technology categories.
• Provides insight into pharmaceutical companies’ preferred buying approaches.
• Comprehend the business and IT objectives that pharmaceutical companies are looking to achieve through their IT investment strategies. 
• Understand the factors that are influencing pharmaceutical companies’ decision to select an ICT provider.

Reasons To Buy
• This report will help readers to understand how the pharmaceutical companies ICT landscape is set to change in 2014.

• Gain a view as to how ICT money is being allocated in your target audience.

• The report covers a detailed breakdown of the opportunities within each of the core areas of ICT spend (hardware, software, IT services, telecommunications and consulting.)

• The report will help users to gain a view of the current strategic objectives of pharmaceutical companies.

• The report will provide a detailed breakdown of the opportunities within selected technology categories (business intelligence, content management, and cloud computing).

• Understand the factors that are influencing pharmaceutical companies’ decision to select an ICT provider.

• Gain a view as to the business and IT objectives pharmaceutical companies are looking to achieve through their ICT investment strategies.


Companies Mentioned

Microsoft, IBM, Oracle, SAP, SAS, Microstrategy, Tibco Spotfire, Information Builders, Google, HP, EMC, Open Text, BT, Verizon, Orange, ATandT, Amazon web services, Rackspace, Salesforce.com, Deutsche Telekom/T-Systems

To view the table of contents and know more details please visit ICT investment trends in pharmaceuticals.